【结 构 式】 |
【分子编号】46329 【品名】2-methyl-6-nitroaniline; 2-methyl-6-nitrophenylamine 【CA登记号】 |
【 分 子 式 】C7H8N2O2 【 分 子 量 】152.1528 【元素组成】C 55.26% H 5.3% N 18.41% O 21.03% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(I)2-Methyl-6-nitroaniline (I) was acylated with 2,6-difluorobenzoyl chloride (II) to afford the nitroanilide (III). Reduction of the nitro group of (III) with concomitant cyclization using iron powder in refluxing HOAc furnished the benzimidazole (IV). Finally, N-alkylation of (IV) with 2,6-difluoro-alpha-bromotoluene (V) in the presence of NaH provided the title compound.
【1】 Morningstar, M.; Roth, T.; Michejda, C.J. (US Department of Health & Human Services); Substd. benzimidazoles as non-nucleoside inhibitors of reverse transcriptase. WO 0114343 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 46329 | 2-methyl-6-nitroaniline; 2-methyl-6-nitrophenylamine | C7H8N2O2 | 详情 | 详情 | |
(II) | 46330 | 2,6-difluorobenzoyl chloride | C7H3ClF2O | 详情 | 详情 | |
(III) | 46331 | 2,6-difluoro-N-(2-methyl-6-nitrophenyl)benzamide | C14H10F2N2O3 | 详情 | 详情 | |
(IV) | 46332 | 2-(2,6-difluorophenyl)-4-methyl-1H-benzimidazole | C14H10F2N2 | 详情 | 详情 | |
(V) | 22316 | 2-(bromomethyl)-1,3-difluorobenzene | 85118-00-9 | C7H5BrF2 | 详情 | 详情 |
Extended Information